NFKB1 and primary effusion lymphoma: The current model of PEL oncogenesis suggests critical roles for inhibition of the p53 family of tumor suppressors and the constitutive activation of nuclear factor kappa B (NF-κB), cytokine, and PI3K/Akt/mTOR signaling pathways.